Although EPORs expression has been demonstrated in different tumor tissues (Kumar et al., 2017), the critical issues regarding the specificity of the commercially available anti-EPOR antibodies for immunohistochemistry have been raised and therefore a consensus on both the expression and potential functional significance of EPORs in cancer cells has not been reached so far (Bennett et al., 2016). The gene discussed is EPOR; the disease is cancer.